Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2022
2022 World Conference on Lung Cancer
As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2015
-
+
EP04.01 - Global Health, Health Services Research, and Health Economics - Cost Issues
- Type: E-Poster
- Track: Global Health, Health Services Research, and Health Economics - Cost Issues
- Presentations: 27
- Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
-
+
EP04.01-001 - Prevalence And Outcomes of EGFR Exon 20 Insertion Mutation In NSCLC: Princess Margaret Cancer Center Experience
Author(s): Abhenil Mittal- Abstract
Loading... -
+
EP04.01-003 - Is It Time for a New Paradigm in Care of Young Cancer Patients? A Retrospective Study
Author(s): Andreina Vasconcelos- Abstract
Loading... -
+
EP04.01-004 - Interim Feedback on Pilot Public Facing Website for Cancer Clinical Trial Patient-Reported Symptom Data: Project Patient Voice
Author(s): Bellinda King-Kallimanis- Abstract
Loading... -
+
EP04.01-006 - A Systematic Review (SR) of Cost-effectiveness Analysis (CEA) of ALK Inhibitors (iALK) in Advance Non-small Cell Lung Cancer (NSCLC)
Author(s): Carolina Gabay- Abstract
Loading... -
+
EP04.01-007 - Impact of Precision Medicine Methods on First-Line Therapies in Metastatic Non-Small Cell Lung Cancer
Author(s): Chetan Vakkalagadda- Abstract
Loading... -
+
EP04.01-008 - Factors Impacting Time from Biopsy to Initiation of Treatment for Advanced NSCLC at an Academic Hospital and Affiliate Hospitals
Author(s): Chetan Vakkalagadda- Abstract
Loading... -
+
EP04.01-010 - Addressing Barriers to Lung Cancer Care for Diverse Populations through Patient Navigation: The University of Miami Experience
Author(s): Estelamari Rodriguez- Abstract
Loading... -
+
EP04.01-011 - Diagnostic Approach and Treatment of Lung Cancer Patients in Portugal: Portuguese Lung Cancer Study Group Survey
Author(s): Fernanda Estevinho- Abstract
Loading... -
+
EP04.01-005 - Lung Cancer Diagnosis Following Emergency Admission: Diagnostic and Therapeutic Pathways and Outcomes Within an Italian Cancer Center
Author(s): Giacomo Vallome- Abstract
Loading... -
+
EP04.01-013 - Frailty Index Predicts Treatment Outcomes in Older Adults with Lung Cancer
Author(s): James Fletcher- Abstract
Loading... -
+
EP04.01-002 - Costs of Locoregional and Metastatic Recurrences in Patients with Resectable Stage II-III NSCLC in Spain
Author(s): Javier de Castro Carpeño- Abstract
Loading... -
+
EP04.01-019 - Into the Wild: Assessing Acute Care for Lung Cancer Patients, A Cohort Study to Improve Cancer Care at Emergency Department
Author(s): Juan Cristóbal Sánchez González- Abstract
Loading... -
+
EP04.01-015 - Lung Cancer after Solid Organ Transplantation - A Claims Data Analysis
Author(s): Julia Walter- Abstract
Loading... -
+
EP04.01-018 - Medical Oncology and Radiation Oncology Consultation in Non-small Cell Lung Cancer (NSCLC). A Population-Based Study Using Administrative Data
Author(s): Michela Febbraro- Abstract
Loading... -
+
EP04.01-017 - Cost-Effectiveness of Atezolizumab for Adjuvant Treatment of Patients with Stage II-IIIA PD-L1+ Non-small Cell Lung Cancer
Author(s): Millie Das- Abstract
Loading... -
+
EP04.01-020 - Impact of Next-Generation Sequencing on Treatment Choice Among Patients with Metastatic NSCLC from the CHUM University Center
Author(s): Myriam Nait Ajjou- Abstract
Loading... -
+
EP04.01-012 - Sex and Age-Related Guideline-Adherence Disparities in Non-Small-Cell Lung Cancer Treatment Patterns: Real-World Data
Author(s): Nelly-Maria Daniela Paakkola- Abstract
Loading... -
+
EP04.01-022 - Real-world Evidence of Durvalumab for Stage III NSCLC: Survival Outcomes and Patterns of Care Post-progression
Author(s): Pedro Aguiar Jr- Abstract
Loading... -
+
EP04.01-009 - Performance Indicators of Lung Cancer MDT at a Regional Center: Disagreements Between Trust and NLCA Data
Author(s): Qudratullah Qudratullah- Abstract
Loading... -
+
EP04.01-023 - Development of an Australia and New Zealand Lung Cancer Clinical Quality Registry (ANZLCR)
Author(s): Robert Stirling- Abstract
Loading... -
+
EP04.01-024 - Influence of Lung Diagnostic Assessment Program on Health Resource Utilization in Lung Cancer in Southeastern Ontario, Canada
Author(s): Shahad AlGhamdi- Abstract
Loading... -
+
EP04.01-026 - Cone-Beam CT Guided Navigation Bronchoscopy: a Cost-Effective Modality for the Diagnosis of Pulmonary Nodules
Author(s): Stephan Elisius Kops- Abstract
Loading... -
+
EP04.01-014 - Adherence to Treatment Recommendations From Multidisciplinary Tumor Boards
Author(s): Julia Roeper- Abstract
Loading... -
+
EP04.01-025 - Implementation of Electronic Patient Reported Outcomes in Routine Cancer Care
Author(s): Afaf Girgis- Abstract
Loading... -
+
EP04.01-027 - Pain and Interventions in Stage IV Non-Small Cell Lung Cancer: A Province-Wide Analysis
Author(s): Vivian S Tan- Abstract
Loading... -
+
EP04.01-029 - Reduction of ER Visits of Lung Cancer Patients Through Care Interventions in Day-To-Day Clinical Service: Experience of a Thoracic Unit in México
Author(s): Saul Campos-Gomez- Abstract
Loading... -
+
EP04.01-021 - Cancer Clinical Quality Registries: A Systematic Review of the Utilisation and Effectiveness of Knowledge Translation Interventions
Author(s): Robert Stirling- Abstract
Loading...
-
+
EP04.02 - Global Health, Health Services Research, and Health Economics - Support to Patients and Staff
- Type: E-Poster
- Track: Global Health, Health Services Research, and Health Economics - Support to Patients and Staff
- Presentations: 5
- Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
-
+
EP04.02-005 - First Comprehensive Lung Cancer Long-Term Survivorship Program - Late Toxicities and Overall Survival
Author(s): Jan-Philipp Exner- Abstract
Loading... -
+
EP04.02-003 - Improving Supportive Care for Patients with Thoracic Cancer
Author(s): LaKedia Charman Banks- Abstract
Loading... -
+
EP04.02-004 - The Patient Impact of Liquid Biopsy - Health-Related Quality of Life in Patients Undergoing Liquid Biopsy for Advanced Non-Small Cell Lung Cancer
Author(s): Lucy Corke- Abstract
Loading... -
+
EP04.02-006 - Burn-Out Syndrome: Neglected Syndrome Among Health Care Professionals Managing Lung Cancer Patients
Author(s): Tomi Kovacevic- Abstract
Loading... -
+
EP04.02-001 - Sex as a Potential Independent Prognostic Factor in Non-Small Cell Lung Cancer Survival
Author(s): Chelsea Ann Ford-Sahibzada- Abstract
Loading...
-
+
EP05.01 - Locally Advanced Non-small Cell Lung Cancer - Chemoradiotherapy and Radiotherapy
- Type: E-Poster
- Track: Locally Advanced Non-small Cell Lung Cancer - Chemoradiotherapy and Radiotherapy
- Presentations: 34
- Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
-
+
EP05.01-015 - Validate Radiomics Features and XGBoost Model in Radiation Pneumonitis (RP) Prediction in Patients with Primary Lung Cancer: A MultiCenter Study
Author(s): Jiali Liu- Abstract
Loading... -
+
EP05.01-018 - Chemoradiotherapy Followed by Durvalumab in Unresectable Locally Advanced NSCLC- A Single Institution Experience in Croatia
Author(s): Ana Bacelic Gabelica- Abstract
Loading... -
+
EP05.01-025 - Planned Interim Analysis of a Phase II Trial of Concurrent Durvalumab and Radiation Therapy for Locally Advanced Lung Cancer
Author(s): Andreas Rimner- Abstract
Loading... -
+
EP05.01-002 - Real World Treatment Patterns and Outcomes among Unresectable Stage III Non-Small Cell Lung Cancer Patients Initiating Chemoradiotherapy
Author(s): ASHWINI ARUNACHALAM- Abstract
Loading... -
+
EP05.01-003 - First Real-World Data on Unresectable Stage III NSCLC Patients Treated with Durvalumab after Chemoradiotherapy in Asia Area
Author(s): ChihHsi Kuo- Abstract
Loading... -
+
EP05.01-006 - Population Kinetic Assessment of Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
Author(s): DAVID J. STEWART- Abstract
Loading... -
+
EP05.01-001 - Hispanic Patients with Unresectable Stage III NSCLC under PACIFIC Protocol: Evidence of Interior Outcomes and Health Inequity
Author(s): Andres F Cardona- Abstract
Loading... -
+
EP05.01-014 - Circulating Tumor DNA to Identify Genomic Biomarkers of Radiation Sensitivity in Locally Advanced Non-Small Cell Lung Cancer
Author(s): Emily Lebow- Abstract
Loading... -
+
EP05.01-008 - The Scottish Inflammatory Prognostic Score predicts survival in non-small cell lung cancer treated with chemoradiotherapy
Author(s): Grace Ball- Abstract
Loading... -
+
EP05.01-033 - Stimulation CT-Based Radiomics Predict Radiation Pneumonitis after Chemoradiotherapy in Locally Advanced NSCLC
Author(s): Liqiao Hou- Abstract
Loading... -
+
EP05.01-011 - Real World Outcomes of Durvalumab after Chemoradiotherapy in unresectable advanced Non-Small Cell Lung Cancer: The Mayo Clinic Experience.
Author(s): Joel Rivera Concepcion- Abstract
Loading... -
+
EP05.01-009 - A Clinical Outcome Comparison of IMRT and VMAT in Stage II and III NSCLC Irradiated with Radical Intent
Author(s): Jose Belderbos- Abstract
Loading... -
+
EP05.01-031 - Lysimachia Capillipes Capilliposide C Enhances the Radiosensitivity of Lung Cancer by Promoting ERRFI1 via Inhibiting Phosphorylation of STAT3
Author(s): Kan Wu- Abstract
Loading... -
+
EP05.01-013 - Increased C-reactive Protein after Chemoradiotherapy and Immunotherapy in Locally Advanced Non-small Lung Cancer Indicates Worse Survival
Author(s): Karmen Stanic- Abstract
Loading... -
+
EP05.01-012 - Avoiding Cardiac Toxicity in Lung Cancer Radiotherapy (ACcoLade) Trial - Initial Results
Author(s): Kathryn Banfill- Abstract
Loading... -
+
EP05.01-017 - Exploring the Benefits of Adaptive Radiotherapy in NSCLC-patients
Author(s): Marie Tvilum- Abstract
Loading... -
+
EP05.01-030 - CRISP: First Real-World Evidence of NSCLC Stage I, II and III in Germany - AIO-TRK-0315
Author(s): Martin Stuschke- Abstract
Loading... -
+
EP05.01-022 - Evaluation of the Management of Stage III NSCLC at Mohamed IV Center for Cancer Treatment Casablanca
Author(s): Maryam ZAOUIT- Abstract
Loading... -
+
EP05.01-020 - Unanticipated Radiation Re-planning for Stage III Non-small Cell Lung Cancer
Author(s): MELINDA MUSHONGA- Abstract
Loading... -
+
EP05.01-021 - Radiation Dose to Cardiac Substructures and the Incidence of Cardiac Events in Patients with Stage III NSCLC Receiving CCRT
Author(s): Meng Xu Welliver- Abstract
Loading... -
+
EP05.01-023 - Feasibility of Functional Lung Avoidance using Ga-68 4D Ventilation Perfusion PET/CT: The HI-FIVE Trial
Author(s): Nicholas Wentworth Bucknell- Abstract
Loading... -
+
EP05.01-024 - Real-life Management of Stage III NSCLC Patients in Italy: The BE-PACIFIC Observational Study
Author(s): Silvia Novello- Abstract
Loading... -
+
EP05.01-010 - External Validation of Two Prediction Models for Severe Radiation-induced Lymphopenia during Concurrent Chemoradiotherapy for Lung Cancer
Author(s): Peter S.N. van Rossum- Abstract
Loading... -
+
EP05.01-027 - Uncertain Resection of pN2 NSCLC Patients-survival Analysis of Postoperative Radiotherapy and Driver Gene Mutations
Author(s): Qianyue Deng- Abstract
Loading... -
+
EP05.01-028 - Thoracic Radiotherapy of Baseline Severe Pulmonary Dysfunction NSCLC Patients and Predictive Analysis for Acute Radiation Pneumonitis
Author(s): Qianyue Deng- Abstract
Loading... -
+
EP05.01-026 - Carboplatin Dose Calculations for Patients with Lung Cancer: Significant Dose Differences Found Depending on Dosing Equation
Author(s): Seçkin Akgül- Abstract
Loading... -
+
EP05.01-005 - Impact of Antibiotic Use Before Definitive Concurrent Chemoradiation in Patients With Locally Advanced Non Small Cell Lung Cancer
Author(s): Ting Mei- Abstract
Loading... -
+
EP05.01-019 - 4D CT Ventilation Image-Guided Lung Functional Avoidance Radiotherapy: A Single-Arm Prospective Pilot Clinical Trial
Author(s): Tokihiro Yamamoto- Abstract
Loading... -
+
EP05.01-029 - Association between DNA Repair Gene Pathway SNPs and Tumour Response in NSCLC Patients Receiving Radiotherapy: A Meta-Analysis
Author(s): Wing San Yiu- Abstract
Loading... -
+
EP05.01-016 - Radiation Recall Pneumonitis (RRP) Induced by Immune Checkpoint Inhibitors (ICIs) after Thoracic Radiotherapy for Lung Cancer
Author(s): Xiaotong Lu- Abstract
Loading... -
+
EP05.01-032 - The Incidence of Brain Metastasis and Radiation Pneumonitis With Durvalumab After Chemoradiotherapy in Unresectable Stage III NSCLC
Author(s): Yeon Sil Kim- Abstract
Loading... -
+
EP05.01-004 - Induction Chemoimmunotherapy before Definitive Chemoradiotherapy for Large-Volume Unresectable Locally Advanced NSCLC
Author(s): Yu Wang- Abstract
Loading... -
+
EP05.01-036 - Role of Nanoparticle Polymeric Micellar Paclitaxel in Reducing Toxicity and Enhancing Efficacy in Non-small Cell Lung Cancer
Author(s): Jun Lu- Abstract
Loading... -
+
EP05.01-007 - CONCORDE - A Phase Ib Platform Study of Novel Agents in COmbinatioN with COnventional RaDiothErapy in Non-small Cell Lung Cancer (NSCLC)
Author(s): Ashley Horne- Abstract
Loading...
-
+
EP05.02 - Locally Advanced Non-small Cell Lung Cancer - Neoadjuvant and Adjuvant Therapy
- Type: E-Poster
- Track: Locally Advanced Non-small Cell Lung Cancer - Neoadjuvant and Adjuvant Therapy
- Presentations: 21
- Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
-
+
EP05.02-014 - Neoadjuvant Toripalimab Combination in Patients with Stage IIB-IIIB NSCLC: A Single-Arm, Phase 2 Trial (Renaissance Study)
Author(s): Shi Yan- Abstract
Loading... -
+
EP05.02-009 - Aumolertinib Versus Erlotinib/Chemotherapy for Neoadjuvant Treatment of Stage IIIA EGFR-mutant NSCLC (ANSWER)
Author(s): Wenhua Liang- Abstract
Loading... -
+
EP05.02-007 - Impact Of Fibrinogen Levels and mGPS on Survival of Stage III/N2 NSCLC Patients Treated with Neoadjuvant Therapy and Radical Surgery
Author(s): Katharina Sinn- Abstract
Loading... -
+
EP05.02-012 - Chemoradiotherapy versus Chemotherapy in Neoadjuvant Settings for Stage III-N2M0 Non-Small Cell Lung Cancer (NSCLC) Patients
Author(s): Marah Akhdar- Abstract
Loading... -
+
EP05.02-010 - Robotic-Assisted Thoracic Surgery Following Neoadjuvant Chemoimmunotherapy in Patients with Stage III Non-small Cell Lung Cancer
Author(s): Yang Gao- Abstract
Loading... -
+
EP05.02-015 - Neoadjuvant Prehabilitation Therapy for Locally Advanced Non-small-Cell Lung Cancer: Optimizing Outcomes throughout the Trajectory of Care.
Author(s): Severin Schmid- Abstract
Loading... -
+
EP05.02-011 - Phase II Trial of Neoadjuvant Tislelizumab with Chemotherapy for Resectable Stage IIB-III Non-small Cell Lung Cancer
Author(s): Yao-Bin Lin- Abstract
Loading... -
+
EP05.02-019 - Transitioning to Neoadjuvant Therapy for Resectable Non-Small Cell Lung Cancer: Surgical Outcomes in a Regionalized Pulmonary Oncology Network
Author(s): Yohann Pilon- Abstract
Loading... -
+
EP05.02-021 - An Updated Analysis of Toripalimab and Platinum-Doublet Chemotherapy as Neoadjuvant Therapy for Potentially Resectable NSCLC
Author(s): Yongchang Zhang- Abstract
Loading... -
+
EP05.02-004 - Could Fifty Percent Tumor Viability Be a Good Prognostic Factor?
Author(s): Suat Erus- Abstract
Loading... -
+
EP05.02-005 - Is Immunotherapy Safer Than Radiotherapy in Combination With Chemotherapy in Neoadjuvant Therapy?
Author(s): Ezgi Cesur- Abstract
Loading... -
+
EP05.02-006 - Neoadjuvant DS-8201 for Stage III Non-small Cell Lung Cancer with HER2 20ins
Author(s): Huizhao Hong- Abstract
Loading... -
+
EP05.02-013 - Immune-Related Adverse Effects and Durvalumab Treatment Patterns in VHA Patients with Unresectable Stage III NSCLC
Author(s): Amanda M Moore- Abstract
Loading... -
+
EP05.02-001 - Early Treatment Failure Of Consolidation Durvalumab for Unresectable Stage III NSCLC: A Real-World Canadian Cohort
Author(s): Amanda Gibson- Abstract
Loading... -
+
EP05.02-002 - Who Benefits More of Durvalumab after Chemoradiotherapy (CRT) in Real-World Patients with Locally Advanced Non-Small-Cell Lung Cancer (NSCLC)?
Author(s): Blanca Távara- Abstract
Loading... -
+
EP05.02-003 - Durvalumab after Chemoradiotherapy (CRT) in Unresectable Stage III NSCLC. Comparative Study of Two Cohorts in the Real-World Setting.
Author(s): Blanca Távara- Abstract
Loading... -
+
EP05.02-008 - Phase II Trial of Neoadjuvant Icotinib Plus Chemotherapy for Stage II-IIIB EGFR-mutant Non-small-Cell Lung Cancer
Author(s): Fang-Liang Lu- Abstract
Loading... -
+
EP05.02-017 - Prognostic Factors Following Induction Therapy for N2 Lung Cancer
Author(s): Takashi Inoue- Abstract
Loading... -
+
EP05.02-016 - Aumolertinib after Adjuvant Chemotherapy/Radiotherapy in Stage pIIIA-N2 Non-Small-Cell Lung Cancer with EGFR Mutation
Author(s): Yu Zhang- Abstract
Loading... -
+
EP05.02-020 - IL-9Stimulates Anti-tumor Immune Response and Facilitates Checkpoint Blockade in Lung Cancer
Author(s): Yuqian Feng- Abstract
Loading... -
+
EP05.02-022 - Thoracic Radiotherapy May Increase the Risk of Treatment-induced Pneumonitis after Immune Checkpoint Inhibitors: A Meta-Analysis
Author(s): Han han- Abstract
Loading...
-
+
EP05.03 - Locally Advanced Non-small Cell Lung Cancer - Surgery
- Type: E-Poster
- Track: Locally Advanced Non-small Cell Lung Cancer - Surgery
- Presentations: 12
- Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
-
+
EP05.03-001 - Impact of Neoadjuvant Chemo/radiotherapy Followed by Surgical Resection on T4N0-1 Non-Small Cell Lung Cancer
Author(s): Akif Turna- Abstract
Loading... -
+
EP05.03-002 - Pulmonary Artery Reconstruction for Lung Cancer With N1 Vessel Infiltration: Is It Justified?
Author(s): Camilla Vanni- Abstract
Loading... -
+
EP05.03-003 - Superior Sulcus (Pancoast) Tumors: A 11-Year Single-Centre Experience
Author(s): Catarina Pereira Moita- Abstract
Loading... -
+
EP05.03-012 - Deep Learning-based Classifier to Predict Intensified Locoregional Approach Need in Stage III Non-Small Cell Lung Cancer
Author(s): Chenchen Zhang- Abstract
Loading... -
+
EP05.03-007 - Comparison of Surgical Methods in Patients Receiving Neoadjuvant Treatment; Thoracoscopy vs. thoracotomy
Author(s): Kadir Burak Ozer- Abstract
Loading... -
+
EP05.03-008 - Surgery after First-Line Alectinib for (Locally) Advanced ALK-rearranged NSCLC: Pathological Response and Peri-Operative Results
Author(s): Filippo Lococo- Abstract
Loading... -
+
EP05.03-005 - Clinical Impact of Histologic Type in Patients with Surgically Resected Stage II and III Non-small Cell Lung Cancer
Author(s): Hyeong Ryul Kim- Abstract
Loading... -
+
EP05.03-004 - Risk Prediction of Multiple-station N2 Metastasis in Patients with Clinical Single-station N2 Non-small Cell Lung Cancer
Author(s): Joon Young Kim- Abstract
Loading... -
+
EP05.03-009 - Prognostic Impact of Tumor Volume Doubling Time for Resected Squamous Cell Carcinoma of the Lung
Author(s): Kenta Nakahashi- Abstract
Loading... -
+
EP05.03-011 - Bilateral Orthotopic Lung Transplantation for a Patient with Advanced Invasive Mucinous Adenocarcinoma
Author(s): Ankit Bharat- Abstract
Loading... -
+
EP05.03-006 - Real-World Treatment Pathways In Stage III Non-Small Cell Lung Cancer in Portugal (PICTuRE): An Interim Analysis Of Surgical Patients
Author(s): Maria Encarnação Teixeira- Abstract
Loading... -
+
EP05.03-010 - Extended Resection of Non-small Cell Lung Cancer with Superior Vena Cava Involvement: A Systematic Review and Meta-analysis
Author(s): Shadi Hamouri- Abstract
Loading...
-
+
EP06.01 - Management of Lung Cancer in the Era of COVID-19
- Type: E-Poster
- Track: Management of Lung Cancer in the Era of COVID-19
- Presentations: 17
- Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
-
+
EP06.01-008 - COVID-Protected Pathways for Image Guided Lunc Cancer Intervention During the COVID-19 Pandemic: A Cohort Study
Author(s): Alexander Sheeka- Abstract
Loading... -
+
EP06.01-001 - The Longitudinal Impact of COVID-19 on the Diagnosis and Treatment of Lung Cancer at a Canadian Academic Centre: A Retrospective Chart Review
Author(s): Angelo Rizzolo- Abstract
Loading... -
+
EP06.01-002 - Cancer Care in a Time of COVID: Lung Cancer Patient’s Experience of Telehealth and Connectedness.
Author(s): Anne Fraser- Abstract
Loading... -
+
EP06.01-005 - COVID-19 and Post-COVID Outcomes in Lung Cancer Patients: Experience from an Indian Cancer Center
Author(s): Debapriya Mondal- Abstract
Loading... -
+
EP06.01-006 - Multidisciplinary Team during the COVID-19 Pandemic: The BE-PACIFIC Italian Observational Study Analysis.
Author(s): SARA RAMELLA- Abstract
Loading... -
+
EP06.01-007 - Fate of Pneumonectomy Patients During Covid-19 Pandemic
Author(s): Gökberk Güler- Abstract
Loading... -
+
EP06.01-009 - Maintaining Thoracic Services During COVID-19 - A Single Centre Experience
Author(s): Hasanali David Walji- Abstract
Loading... -
+
EP06.01-010 - Clinical Outcomes after Hypo Fractionated Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer During The Covid-19 Pandemic In Morocco
Author(s): Meriem cherkaoui- Abstract
Loading... -
+
EP06.01-011 - COVID-19 Impact in Thoracic Surgery: a Comparison Between Public and Private Care in a Single-Center Facility
Author(s): Paulo Alfredo Schulze- Abstract
Loading... -
+
EP06.01-013 - Differences of Oncology Treatment for Lung Cancer Patients in Pandemic COVID-19 Yearꓽ Our Clinical Experience
Author(s): simonida crvenkova- Abstract
Loading... -
+
EP06.01-012 - Impact of COVID-19 on the Stage of Lung Cancer Diagnosis at the Mohamed VI Center for Cancer Treatment in Morocco
Author(s): Souleymane PANANDTIGRI- Abstract
Loading... -
+
EP06.01-015 - Will Virtual Care Stand the Test of Time; One Site’s Perspective on the Continuity of Virtual Care Post-Pandemic
Author(s): Suheon Lee- Abstract
Loading... -
+
EP06.01-003 - Impact of COVID-19 on Lung Cancer Patients; The Patients’ Perspective
Author(s): Sunil Samnani- Abstract
Loading... -
+
EP06.01-016 - Nationwide Activity of Lung Cancer Surgery Before and During the COVID-19 Pandemic
Author(s): Tanel Laisaar- Abstract
Loading... -
+
EP06.01-004 - Lung Cancer Resection During the Covid-19 Pandemic: A Single Centre Study
Author(s): Tunde Nureini Oyebanji- Abstract
Loading... -
+
EP06.01-017 - Clinical Impact of SARS-CoV2 Pandemic in the Diagnosis of Early-Stage Thoracic Tumours
Author(s): Yago Garitaonaindía Díaz- Abstract
Loading... -
+
EP06.01-014 - Lung Resections After COVID: Short-term Outcomes
Author(s): Srinivas Kodaganur Gopinath- Abstract
Loading...
-
+
EP07.01 - Mesothelioma, Thymoma, and Other Thoracic Malignancies - Clinical
- Type: E-Poster
- Track: Mesothelioma, Thymoma, and Other Thoracic Malignancies - Clinical
- Presentations: 26
- Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
-
+
EP07.01-004 - Long Survivor Epithelioid Pleural Mesotheliomas Are Characterized by Tertiary Lymphoid Structures: An Update to the MATCH Study
Author(s): Federica Grosso- Abstract
Loading... -
+
EP07.01-001 - Molecular Profiling Predicts Outcomes in Patients With Resected Malignant Pleural Mesothelioma
Author(s): Christian Diego Rolfo- Abstract
Loading... -
+
EP07.01-005 - Second Primary Cancers in a Population-Based Mesothelioma Registry
Author(s): Alessandro D'Aveni- Abstract
Loading... -
+
EP07.01-007 - Is Extended Resection for Tracheo Bronchial Adenoid Cystic Carcinoma Warranted ?
Author(s): Jérôme Estephan- Abstract
Loading... -
+
EP07.01-009 - Solitary Fibrous Tumors of the Pleura, Clinical and Surgical Dilemma. Single-Center Experience
Author(s): Krzysztof Kurowski- Abstract
Loading... -
+
EP07.01-010 - Results of Multimodal Treatment in Patients with Malignant Pleural Mesothelioma Undergoing Pleurectomy/Decortication
Author(s): Kubra Alphan Kavak- Abstract
Loading... -
+
EP07.01-020 - Pulmonary MALT Lymphoma: Detailed CT Findings
Author(s): Kyongmin Sarah Beck- Abstract
Loading... -
+
EP07.01-011 - Integrating PD-L1 Expression to the CALGB Prognostic Scoring System in Malignant Pleural Mesothelioma
Author(s): Luis Antonio Cabrera- Abstract
Loading... -
+
EP07.01-021 - Clinical and Biochemical Profiling of Pleural Mesothelioma Patients Treated With Immunotherapy
Author(s): Mario Occhipinti- Abstract
Loading... -
+
EP07.01-012 - Ipilimumab and Nivolumab in Pretreated Patients with Malignant Pleural Mesothelioma
Author(s): Marko Jakopovic- Abstract
Loading... -
+
EP07.01-013 - Physical Function, Symptom Burden, and Quality of Life in Patients with Malignant Pleural Mesothelioma
Author(s): Meng Wu- Abstract
Loading... -
+
EP07.01-015 - Multimodality Imaging for Characterization, Classification, and Staging of Malignant Pleural Mesothelioma, Focusing on MR Imaging
Author(s): Mi young Kim- Abstract
Loading... -
+
EP07.01-014 - Mesothelioma-Associated Fibroblasts Enhance Mesothelioma Aggressiveness and Modulate Drug Response
Author(s): Alexander Ries- Abstract
Loading... -
+
EP07.01-006 - Clinicopathologic Determinants of Survival in Thoracic NUT Carcinoma (TNUT): Analysis of a Pooled Database
Author(s): Philip A Haddad- Abstract
Loading... -
+
EP07.01-002 - Surgery in Stage I-III Malignant Pleural Mesothelioma: A Surveillance, Epidemiology, and End Results (SEER)- Medicare Analysis 1995-2015
Author(s): Qian Wang- Abstract
Loading... -
+
EP07.01-016 - Role of Neoadjuvant Chemotherapy in Thymic Tumors
Author(s): riad abdeljalil- Abstract
Loading... -
+
EP07.01-019 - Multiinstitutional Patterns of Use and Compliance with Tumor Treating Fields for Patients with Unresectable Malignant Pleural Mesothelioma
Author(s): Tugce Kutuk- Abstract
Loading... -
+
EP07.01-017 - Malignant Fibrous Solitary Tumour of the Pleura Is Not All the Same: Evaluation of Risk Stratification Models in a Large Single Centre Series
Author(s): Sara Ricciardi- Abstract
Loading... -
+
EP07.01-025 - Survival Advantage of Pulmonary Metastasectomy in Advanced Melanoma Patients: A Population-Based Study
Author(s): Sebawe Syaj- Abstract
Loading... -
+
EP07.01-024 - Preclinical Investigation of Immune Checkpoint Blockade and Anti-Angiogenic Therapy in Malignant Pleural Mesothelioma
Author(s): Sophie Rovers- Abstract
Loading... -
+
EP07.01-023 - Family History of Cancer in a Series of Malignant Pleural Mesothelioma (MPM) Patients (P)
Author(s): Susana Cedres- Abstract
Loading... -
+
EP07.01-008 - Perturbation of Warburg Effect by Dichloroacetate and Niclosamide in Malignant Pleural Mesothelioma in Vitro and in Vivo
Author(s): Sze Kwan LAM- Abstract
Loading... -
+
EP07.01-026 - Primary Pulmonary Ewing´S Sarcoma: Post Hoc Analysis From Two International Multicenter Prospective Randomized Trials
Author(s): Theresa Stork- Abstract
Loading... -
+
EP07.01-003 - Metadata-Oriented Data Engineering Approach for Integration of Medical Data: A Pilot Study
Author(s): Yusuf Kahya- Abstract
Loading... -
+
EP07.01-022 - Analysis of Second Surgery for Recurrence in Malignant Pleural Mesothelioma (MPM) Patients (P)
Author(s): Susana Cedres- Abstract
Loading... -
+
EP07.01-018 - Phase III Randomized Trial on Surgery, Chemo and Pleural Radiation (IMPRINT) for Resectable Pleural Mesothelioma (NRG LU-006)
Author(s): Andreas Rimner- Abstract
Loading...
-
+
EP07.02 - Mesothelioma, Thymoma, and Other Thoracic Malignancies - Preclinical
- Type: E-Poster
- Track: Mesothelioma, Thymoma, and Other Thoracic Malignancies - Preclinical
- Presentations: 4
- Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
-
+
EP07.02-003 - Characterization of the Extracellular Vesicle-Derived Transcriptome in Malignant Pleural Mesothelioma
Author(s): Agnieszka Kraft- Abstract
Loading... -
+
EP07.02-001 - Evaluation of FGF18 as a Contributing Factor in Malignant Pleural Mesothelioma Growth and Its Role as a Potential Biomarker
Author(s): Berta Mosleh- Abstract
Loading... -
+
EP07.02-002 - Investigating the Role of MicroRNAs in Cell Growth and Cisplatin-Sensitivity of Malignant Pleural Mesothelioma
Author(s): Michaela B Kirschner- Abstract
Loading... -
+
EP07.02-004 - Endogenous Retrovirus Expression and Type I Interferon Signaling in Human Mesothelioma
Author(s): Suna Sun- Abstract
Loading...
-
+
EP07.03 - Mesothelioma, Thymoma, and Other Thoracic Malignancies - Thymoma
- Type: E-Poster
- Track: Mesothelioma, Thymoma, and Other Thoracic Malignancies - Thymoma
- Presentations: 7
- Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
-
+
EP07.03-002 - Combined Classifications for Thymoma and Thymic Carcinoma From a 10 years CHUM University Hospital Real-world Experience
Author(s): Camille Gauvin- Abstract
Loading... -
+
EP07.03-001 - Comparison of Treatment Outcomes in Neoadjuvant Chemotherapy and Chemo-radiotherapy for Thymoma and Thymic Carcinoma
Author(s): Hyeon Seok Choi- Abstract
Loading... -
+
EP07.03-004 - Efficacy of Thoracic Radiotherapy for Local Progression in Advanced Thymic Carcinoma
Author(s): Mao Uematsu- Abstract
Loading... -
+
EP07.03-005 - MesoGraph: Graph Neural Networks for Weakly Supervised Cellular Profiling in the Subtyping of Malignant Mesothelioma Images
Author(s): Mark Eastwood- Abstract
Loading... -
+
EP07.03-006 - Feasibility of TTFields with Pemetrexed and Platinum-Based Chemotherapy for Unresectable Malignant Pleural Mesothelioma: Real-World Data
Author(s): Tugce Kutuk- Abstract
Loading... -
+
EP07.03-007 - Clinicopathological Analyses for Predicting Recurrence After Complete Resection of Thymoma
Author(s): Takahiro Suzuki- Abstract
Loading... -
+
EP07.03-003 - First Line Combination of Toripalimab and Chemotherapy in Advanced Thymic Carcinoma: A Single-Center, Prospective, Single-Arm, Phase II Trial
Author(s): Xingsheng Hu- Abstract
Loading...
-
+
EP08.01 - Metastatic Non-small Cell Lung Cancer - Immunotherapy
- Type: E-Poster
- Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
- Presentations: 108
- Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
-
+
EP08.01-015 - Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Anti-oxMIF Antibody ON203 in Malignant Solid Tumors
Author(s): Christine Landlinger-Schubert- Abstract
Loading... -
+
EP08.01-016 - A Review Of Real-World Treatment Outcomes Of mNSCLC Patients Following Progression On Or After Platinum-Based Chemotherapy
Author(s): Cloe Ying Chee Koh- Abstract
Loading... -
+
EP08.01-018 - Patterns of Failure in Metastatic NSCLC Treated with First Line Pembrolizumab and Impact of Local Therapy in Patients with Oligoprogression
Author(s): Cole Friedes- Abstract
Loading... -
+
EP08.01-019 - Modifiable biomarkers of response to immune checkpoint inhibitor treatment in non-small cell lung cancer
Author(s): Daniel Spakowicz- Abstract
Loading... -
+
EP08.01-020 - Phase 2 Platform Trial of Anti-TIGIT GSK’859A/EOS-448 + Anti-PD-1 Dostarlimab in Non-small Cell Lung Cancer (NSCLC)
Author(s): David Spigel- Abstract
Loading... -
+
EP08.01-078 - Clinical Outcomes in Metastatic Non-small Cell Lung Cancer Harboring BRAF Mutations Treated With Immune Checkpoint Inhibitors
Author(s): David Garcia-Illescas- Abstract
Loading... -
+
EP08.01-027 - Durvalumab (D) ± Tremelimumab (T) + Chemotherapy (CT) in 1L Metastatic NSCLC: Outcomes by Tumour PD-L1 Expression in POSEIDON
Author(s): Edward B. Garon- Abstract
Loading... -
+
EP08.01-028 - Overestimation with Cox HR - Cox-TEL-Adjusted Associations of PD-L1 Expression with Immune Checkpoint Inhibitor Survival Benefit in Lung Cancer
Author(s): Emily Pei-Ying Lin- Abstract
Loading... -
+
EP08.01-029 - NIVIPI-BRAIN, A Phase II Study of Nivolumab plus Ipilimumab Combined with Chemotherapy for Patients with NSCLC and Synchronous Brain Metastases
Author(s): Ernest Nadal- Abstract
Loading... -
+
EP08.01-026 - Influence of Brain Metastases on Survival of KRASG12C Mutated Stage IV Immune Checkpoint Inhibitor Treated Non-Small Cell Lung Cancer Patients
Author(s): Esther M Swart- Abstract
Loading... -
+
EP08.01-034 - Association of Sarcopenia with Survival in Advanced NSCLC Patients Receiving Concurrent Immunotherapy and Chemotherapy
Author(s): Fabian Johannes Bolte- Abstract
Loading... -
+
EP08.01-031 - Blood Gene Expression Changes in Metastatic Lung Cancer under second-line Immunotherapy according to Clinical Response
Author(s): Fabienne Dorothea Lusky- Abstract
Loading... -
+
EP08.01-039 - Impact of Pulmonary Function Indexes on Immunotherapy Efficacy in Lung Adenocarcinoma Patients and the Potential Prognostic Factors
Author(s): Fang Hu- Abstract
Loading... -
+
EP08.01-038 - Clinical Predictors of Treatment Efficacy in Patients with Lung Adenocarcinoma Receiving Immune Checkpoint Inhibitors
Author(s): Fang Hu- Abstract
Loading... -
+
EP08.01-030 - Nivolumab+Ipilimumab Vs Platinum-Based CT+Nivolumab In Advanced Lung Squamous-Cell Carcinoma: The Randomized SQUINT Trial
Author(s): Angelo Delmonte- Abstract
Loading... -
+
EP08.01-089 - Efficacy and Safety of Immune Checkpoint Inhibitors in Treating Brain Metastases in Patients With Non-small Cell Lung Cancer
Author(s): Fei Teng- Abstract
Loading... -
+
EP08.01-072 - Clinical Value of Patras Immunotherapy Score (PIOS) Formula in Patients With Advanced NSCLC Treated With Immunotherapy/Chemotherapy
Author(s): Foteinos-Ioannis Dimitrakopoulos- Abstract
Loading... -
+
EP08.01-035 - Personalized ctDNA Detection to Monitor Outcome and Predict Immunotherapy Benefit in Locally Advanced and Metastatic NSCLC
Author(s): Guanghui Gao- Abstract
Loading... -
+
EP08.01-083 - Real-World PD-(L)1 Inhibitor Treatment Pattern and Outcomes in Advanced Non-Small Cell Lung Cancer in Sweden
Author(s): Gunnar Wagenius- Abstract
Loading... -
+
EP08.01-036 - Low-dose EGFR-TKIs Directly Induce Maturation and Functional Activity of Human Dendritic Cells in an EGFR-independent manner
Author(s): Hiroyuki Inoue- Abstract
Loading... -
+
EP08.01-037 - Association of Baseline NLR and BMI with Clinical Outcomes in NSCLC Patients Treated with Immunotherapy Alone Versus Chemo-Immunotherapy
Author(s): Hita Moudgalya- Abstract
Loading... -
+
EP08.01-001 - Update Analysis of Sintilimab With Two Cycles Chemotherapy for Untreated Advanced Squamous Non-small-Cell Lung Cancer
Author(s): Huijuan Wang- Abstract
Loading... -
+
EP08.01-023 - Factors Associated with Survival and Refusal of Physician Recommended Immunotherapy in Metastatic Non Small Cell Lung Cancer
Author(s): Iktej Singh Jabbal- Abstract
Loading... -
+
EP08.01-040 - Peripheral Blood Cells as Predictors for Efficacy of Immunotherapy in Patients with Advanced Non-small Cell Lung Cancer
Author(s): Jacobo Rogado- Abstract
Loading... -
+
EP08.01-041 - Impact of Gender on Response to Immune Checkpoint Inhibitors in Patients with Non-small Cell Lung Cancer
Author(s): Jae Cheol Lee- Abstract
Loading... -
+
EP08.01-090 - Association of Gender and Outcomes in Patients With Advanced NSCLC Treated With Immunotherapy Alone or in Combination With Chemotherapy Upfront.
Author(s): Javier Torres Jiménez- Abstract
Loading... -
+
EP08.01-049 - Unscheduled Hospitalizations in Patients With Thoracic Tumors in the Era of Immunotherapy
Author(s): Jesús Peña-López- Abstract
Loading... -
+
EP08.01-043 - Clinicopathologic and Genomic Factors Impacting Efficacy of First-Line Chemoimmunotherapy in Advanced Non-small Cell Lung Cancer (NSCLC)
Author(s): Joao Alessi- Abstract
Loading... -
+
EP08.01-044 - A Phase 2 Multi-Cohort Study of Tiragolumab, Atezolizumab and Bevacizumab in Advanced Non-Squamous Non-Small Cell Lung Cancer
Author(s): Joshua Reuss- Abstract
Loading... -
+
EP08.01-107 - The Increase of Blood Intratumor Heterogeneity Is Associated with Unfavorable Outcomes of ICIs Plus Chemotherapy in NSCLC
Author(s): Juan Zhou- Abstract
Loading... -
+
EP08.01-066 - Assessing Immunotherapy in Real Life: Have We Transferred the Increase in Overall Survival in Stage IV NSCLC from Trials to Clinical Practice?
Author(s): Juan Cristóbal Sánchez González- Abstract
Loading... -
+
EP08.01-045 - The Impact of Current Smoking Status at Initiation of Immune Checkpoint Inhibitor Therapy on Tumor Mutation Burden and Survival
Author(s): Julie T. Wu- Abstract
Loading... -
+
EP08.01-070 - Safety and Efficacy of Sitravatinib + Tislelizumab in Patients with PD-L1+, Locally Advanced/Metastatic, Squamous NSCLC
Author(s): Jun Zhao- Abstract
Loading... -
+
EP08.01-071 - Safety and Efficacy of Sitravatinib + Tislelizumab in Patients with PD-L1+, Locally Advanced/Metastatic, Non-Squamous NSCLC
Author(s): Jun Zhao- Abstract
Loading... -
+
EP08.01-002 - Real-World Survival Outcomes of Patients with High PD-L1 Advanced NSCLC Who Received Chemo-Immunotherapy vs Immunotherapy
Author(s): Junipearl Cheng- Abstract
Loading... -
+
EP08.01-046 - Examination of Long-Term Administration of Pembrolizumab in Patients with Non-small Cell Lung Cancer at Our Institution
Author(s): Kazuhito Nii- Abstract
Loading... -
+
EP08.01-047 - Chemo-immunotherapy is Associated With Better Survival Than Chemotherapy Alone In Stage IV Non-small Cell Lung Cancer
Author(s): Krishna Hitendra Patel- Abstract
Loading... -
+
EP08.01-048 - Spanish Immunotherapy Registry of Cardiovascular Toxicity (SIR-CVT): Preliminary Analysis of the Lung Cancer Cohort
Author(s): Laura Gutiérrez Sainz- Abstract
Loading... -
+
EP08.01-050 - Survival Outcome of Metastatic Pulmonary Sarcomatoid Carcinoma Treated with Immunotherapy: An Analysis of National Cancer Database (NCDB)
Author(s): Lei Deng- Abstract
Loading... -
+
EP08.01-102 - Anlotinib Combined with PD-1 Inhibitors May Benefit Advanced Non-small Cell Lung Cancer Patients After Failure of EGFR-TKI Therapy
Author(s): Lian Yu- Abstract
Loading... -
+
EP08.01-103 - Combination of Anlotinib and PD-1/PD-L1 Inhibitors as Second-line and Subsequent Therapy in Advanced Small-cell Lung Cancer
Author(s): Lian Yu- Abstract
Loading... -
+
EP08.01-095 - Efficacy and Safety of Combining Endostar with Camrelizumab plus Chemotherapy in Advanced NSCLC Patients: A Multi-Center Retrospective Study
Author(s): Lin Wu- Abstract
Loading... -
+
EP08.01-093 - ICI in Combination With Chemotherapy or Anti-angiogenic Agents as Second-Line Orbeyondtreatment for Advanced Non-small Cell Lung Cancer
Author(s): Lin Wu- Abstract
Loading... -
+
EP08.01-094 - A Phase II Study of Camrelizumab combined with Apatinib and Albumin Paclitaxel in Advanced Non-squamous NSCLC (CAPAP-lung)
Author(s): Lin Wu- Abstract
Loading... -
+
EP08.01-099 - Activity of aPD1-MSLN-CART Cells against Metastatic Lung Cancer in a Phase 1 Trial
Author(s): Lingjuan Chen- Abstract
Loading... -
+
EP08.01-106 - PD-1/PD-L1 Inhibitors Increase Myocardial Infarction in Osimertinib-Treated Patients with Non-Small Cell Lung Cancer
Author(s): Lucheng Zhu- Abstract
Loading... -
+
EP08.01-060 - Long term Survival Outcomes in NSCLC Patients with Targeted Therapy and Immunotherapy: An IASLC Analysis of ASCO CancerLinQ Discovery Data
Author(s): Madhusmita Behera- Abstract
Loading... -
+
EP08.01-058 - Access to Immunotherapy in Control Arms of Pivotal First Line Immunotherapy Trials in Metastatic Non-Small Cell Lung Cancer
Author(s): Maham Bakhtyar- Abstract
Loading... -
+
EP08.01-088 - Direct Acting Antivirals (DAA) and Immune Checkpoint Inhibitors (ICIs) Therapy in Patients with Lung Cancer and Hepatitis C
Author(s): Marco Tagliamento- Abstract
Loading... -
+
EP08.01-065 - Prevalence of Non-driver Mutations and Characterization of Patients with Advanced or Metastatic Non-small Cell Lung Cancer
Author(s): Mariano Provencio- Abstract
Loading... -
+
EP08.01-057 - Pembrolizumab Maintenance in Patients with Metastatic Squamous Non-Small Cell Lung Cancer (sNSCLC) - AIO-TRK-0115/PRIMUS
Author(s): Martin Reck- Abstract
Loading... -
+
EP08.01-061 - A Pilot Study of Avelumab and SABR in Non-Responding and Progressing NSCLC Patients Previously Treated with a Checkpoint Inhibitor
Author(s): Megan Eileen Daly- Abstract
Loading... -
+
EP08.01-005 - A Multicenter Prospective Observational Study of Atezolizumab in Unresectable Advanced or Metastatic NSCLC in Japan: J-TAIL
Author(s): Akito Hata- Abstract
Loading... -
+
EP08.01-007 - Real-World Outcomes of Patients with Advanced Lung Adenocarcinoma Treated with First-Line Chemo-Immunotherapy in Italy
Author(s): Alessandro Leonetti- Abstract
Loading... -
+
EP08.01-008 - Immune Checkpoint Inhibitors in Oncogenic Driven Non-small Cell Lung Cancer
Author(s): Ana Fonseca- Abstract
Loading... -
+
EP08.01-004 - Pattern of Subsequent Treatment and Outcomes in Relapsed PD-L1 high NSCLC Pre-treated with Pembrolizumab
Author(s): Anifat Elegbede- Abstract
Loading... -
+
EP08.01-096 - Lung Immune Prognostic Index is Prognostic in Patients Treated with PD-1 Inhibitor Combined with Chemotherapy for Non-small Cell Lung Cancer
Author(s): Anning Xiong- Abstract
Loading... -
+
EP08.01-006 - Using Real World data to build effective predictive machine learining models for NSCLC patients treated with immune-based therapy
Author(s): Arsela Prelaj- Abstract
Loading... -
+
EP08.01-011 - Diabetes Mellitus (DM) is Associated with Poor Outcome in Pembrolizumab-treated Non-Small Cell Lung Cancer (NSCLC) Patients
Author(s): Barliz Waissengrin- Abstract
Loading... -
+
EP08.01-010 - Troponin Elevation and the Risk of Myocarditis among NSCLC Patients Treated with Immune Checkpoint Inhibitors
Author(s): Barliz Waissengrin- Abstract
Loading... -
+
EP08.01-012 - First-line Chemo-Immunotherapy in Advanced Non-Small Cell Lung Cancer with 0-49% PD-L1: A Real-world Experience
Author(s): Beatrice Benetti- Abstract
Loading... -
+
EP08.01-080 - Tislelizumab Plus Chemotherapy as First-Line Treatment for Advanced NSCLC in Patients aged ≥ 70
Author(s): Bo Shen- Abstract
Loading... -
+
EP08.01-013 - Ramucirumab plus Atezolizumab in Patients with Stage IV NSCLC Previously Treated with Immune Checkpoint Blockade
Author(s): Brett Howard Herzog- Abstract
Loading... -
+
EP08.01-017 - Evaluation of Blood Tumor Mutation Burden for Efficacy of Second- Line Atezolizumab Treatment in Non-small Cell Lung Cancer
Author(s): Cheol-Kyu Park- Abstract
Loading... -
+
EP08.01-059 - Safety, Tolerability and Clinical Activity of Selinexor in Combination with Pembrolizumab in Metastatic Non-small Cell Lung Cancer
Author(s): Mehmet Altan- Abstract
Loading... -
+
EP08.01-064 - Serum NY-ESO-1 and XAGE1 Antibodies Predict and Monitor Clinical Responses to Immune Checkpoint Therapy for NSCLC
Author(s): Mikio Oka- Abstract
Loading... -
+
EP08.01-062 - Body Mass Index, Immune Related Adverse Events, and Survival in Patients with Metastatic Non-small Cell Lung Cancer Treated with Immunotherapy
Author(s): Mingjia Li- Abstract
Loading... -
+
EP08.01-063 - Chemoimmunotherapy versus Immunotherapy for First Line Treatment of Advanced Non-small Cell Lung Cancer with a PD-L1 Score of 50-100%
Author(s): Mohsin Shah- Abstract
Loading... -
+
EP08.01-068 - Going for the Ligand After a Stint With the Receptor: Can Switching Target From PD-1 to PD-L1 (Or Vice-Versa) Be Beneficial?
Author(s): Nida Khan- Abstract
Loading... -
+
EP08.01-069 - A Retrospective Study of Immune Checkpoints Rechallenge/ Retreatment in Metastatic NSCLC Progressing after Previous ICIs
Author(s): Nuria Neisy Mederos Alfonso- Abstract
Loading... -
+
EP08.01-024 - Multicenter Real Life Clinical Outcomes of PDL-1 Tested Patients with Non Small Cell Lung Cancer (NSCLC) in Turkey
Author(s): Ozan Yazici- Abstract
Loading... -
+
EP08.01-100 - Unlocking Primary Resistance to Checkpoint Inhibitors in Non-small Cell Lung Cancer by Metagenomic and Metabolomic
Author(s): Peng Ding- Abstract
Loading... -
+
EP08.01-074 - 'Long Responders' Compared to 'Non-Responders' to a First Line Immune Checkpoint Inhibitor in Incurable Non-Small Cell Lung Cancer
Author(s): Rebekah Rittberg- Abstract
Loading... -
+
EP08.01-075 - Combination of Baseline Disease and Smoking Pack-Years Can Guide The 1st-line Treatment Decision in Advanced NSCLC with High PD-L1 Expression
Author(s): Ren Yuan- Abstract
Loading... -
+
EP08.01-076 - KEYNOTE B36: A Pilot Study of First-line Tumor Treating Fields (150 kHz) Plus Pembrolizumab for Advanced or Metastatic Non-small Cell Lung Cancer
Author(s): Rupesh Kotecha- Abstract
Loading... -
+
EP08.01-086 - Pooled Mutant KRAS-Targeted Peptide Vaccine with Nivolumab and Ipilimumab in Advanced KRAS Mutated Non-Small Cell Lung Cancer
Author(s): Samuel Rosner- Abstract
Loading... -
+
EP08.01-051 - Clinical Characterization and Outcomes of Non Small Cell Lung Cancer with HER2 Alterations in the Era of Immunotherapy
Author(s): Shenduo Li- Abstract
Loading... -
+
EP08.01-021 - Phase 2 Study Evaluating Inupadenant in Combination with Chemotherapy in Adults with NSCLC who Progressed on Immunotherapy
Author(s): SHOURYADEEP SRIVASTAVA- Abstract
Loading... -
+
EP08.01-081 - A Phase I Dose-Escalation Study of HBM4003, an anti-CTLA-4 Heavy Chain Only Monoclonal Antibody, in Combination with Pembrolizumab
Author(s): Shun Lu- Abstract
Loading... -
+
EP08.01-082 - Therapeutic Resistance and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated NSCLC Patients: A Prospective Study
Author(s): Shun Lu- Abstract
Loading... -
+
EP08.01-077 - Predicting Response to Checkpoint Inhibitors Using Complex Molecular Characteristics and Immunoprofiling in Patients With NSCLC
Author(s): Simona Borilova- Abstract
Loading... -
+
EP08.01-084 - Non-Invasive Detection of Predictive Biomarkers for PD-1 Inhibitor Treated Non-Small Cell Lung Cancer Patients
Author(s): Simone Stensgaard- Abstract
Loading... -
+
EP08.01-025 - PD-L1 Tumor Tissue Expression and Its Relation with Clinico-pathological Profile in Advanced NSCLC
Author(s): Sindhu Kilaru- Abstract
Loading... -
+
EP08.01-085 - Sintilimab versus Pembrolizumab as Monotherapy or in Combination with Chemotherapy for Treatment Naïve Metastatic Non-small Cell Lung Cancer
Author(s): Si-Yang Maggie Liu- Abstract
Loading... -
+
EP08.01-087 - First-Line Pembrolizumab-Combination Therapy for Advanced Squamous NSCLC: Real-World Outcomes at US Oncology Practices
Author(s): Stephen V. Liu- Abstract
Loading... -
+
EP08.01-091 - Association of dNLR Score with Outcomes in Patients with Advanced NSCLC Under Immunotherapy Alone +/- Chemotherapy Upfront
Author(s): Teresa Gorria- Abstract
Loading... -
+
EP08.01-067 - Rechallenging with PD-1 Inhibitors: Incidence and Management of Immune-Related Adverse Events in Metastatic NSCLC
Author(s): Tuan Hoang- Abstract
Loading... -
+
EP08.01-108 - Real-Life Costs and Benefit of First-Line Pembrolizumab for Advanced NSCLC - A Propensity-Score Matched Case-Control Study
Author(s): Vanessa Rambousek- Abstract
Loading... -
+
EP08.01-055 - Utilization of Tumor Mutational Profiling to Identify the Immunotherapy Response in Non-small Cell Lung Cancer
Author(s): Peng Song- Abstract
Loading... -
+
EP08.01-097 - Landscape and Dynamic Changes of Peripheral Immune Cells in Non-small Cell Lung Cancer Patients with First-line Immunotherapy
Author(s): Xiangling Chu- Abstract
Loading... -
+
EP08.01-098 - Evaluating Risk Factors for Pneumonitis in Stage III NSCLC Patients Receiving Durvalumab after Definitive Chemoradiation
Author(s): xiaokui Mo- Abstract
Loading... -
+
EP08.01-009 - TRBV Haplotype Profile Was Related to Immune-Induced Adverse Events in Chinese Patients With Advanced NSCLC
Author(s): Xiaomin Niu- Abstract
Loading... -
+
EP08.01-056 - Pemetrexed-Based Chemotherapy Plus ICIs or Bevacizumab as First-Line Strategy for Patients with Lung Adenocarcinoma in Real-World Setting
Author(s): Xin Li- Abstract
Loading... -
+
EP08.01-052 - Toripalimab in Combination with CIK Cells in Patients with Advanced NSCLC: An Exploratory Study
Author(s): Baohui Han- Abstract
Loading... -
+
EP08.01-022 - Treatment Outcomes of Second-Line Immune Modulators in Steroid Refractory/Resistant Immune Related Adverse Events
Author(s): Yasar Ahmed- Abstract
Loading... -
+
EP08.01-042 - NEPTUNE China Cohort: First-Line Durvalumab + Tremelimumab versus Chemotherapy in Chinese Patients with Metastatic NSCLC
Author(s): Ying Cheng- Abstract
Loading... -
+
EP08.01-101 - Factors Predictive of Primary Resistance to Immune Checkpoint Inhibitors in Asian Patients with Advanced NSCLC
Author(s): Yiqing Huang- Abstract
Loading... -
+
EP08.01-105 - Efficacy of First-Line Immune Checkpoint Inhibitors in Patients with Advanced NSCLC harboring KRAS, MET, FGFR, RET, BRAF, and HER2 Alterations
Author(s): Yuji Uehara- Abstract
Loading... -
+
EP08.01-104 - Baseline Tumor Size and Survival Outcomes among Patients with Advanced NSCLC treated with First-Line Immunotherapy
Author(s): Yuji Uehara- Abstract
Loading... -
+
EP08.01-033 - ML40471: Preliminary Analysis of Atezolizumab in Previously Treated Patients With Locally Advanced or Metastatic NSCLC
Author(s): Zhiyu Huang- Abstract
Loading... -
+
EP08.01-032 - Sintilimab in Combination with Anlotinib in NSCLC Patients with Uncommon EGFR Mutations: A Phase II, Single-arm, Prospective Study
Author(s): Yun Fan- Abstract
Loading... -
+
EP08.01-054 - ICIs combined with Single-agent Chemotherapy in Two or More Lines Treatment for Advanced Non-Small Cell Lung Cancer
Author(s): Yutao Liu- Abstract
Loading... -
+
EP08.01-053 - PD-1 Inhibitors Plus Chemotherapy in Patients with Brain Metastasis and EGFR/ALK-positive Non-small Cell Lung Cancer after EGFR/ALK-TKIs
Author(s): Yutao Liu- Abstract
Loading... -
+
EP08.01-003 - Efficacy of Immune Checkpoint Inhibitors in Pulmonary Sarcomatoid Carcinoma, A Multicenter Retrospective Study
Author(s): Zhimin Zeng- Abstract
Loading... -
+
EP08.01-014 - Tislelizumab versus Docetaxel in Previously Treated Advanced Non-Small Cell Lung Cancer: Final Analysis of RATIONALE-303
Author(s): Caicun Zhou- Abstract
Loading... -
+
EP08.01-109 - TACTI-002: A Phase II Study of Eftilagimod Alpha (Soluble LAG-3) & Pembrolizumab in 2nd line PD-1/PD-L1 Refractory Metastatic NSCLC
Author(s): Martin Forster- Abstract
Loading... -
+
EP08.01-110 - Trial in Progress: A Phase 2 Multicenter Study (IOV-LUN-202) of Autologous Tumor-infiltrating Lymphocyte (TIL) Cell Therapy (LN-145) in mNSCLC
Author(s): Jason Alan Chesney- Abstract
Loading... -
+
EP08.01-073 - AdvanTIG-105: Phase 1b Dose-Expansion Study of Ociperlimab plus Tislelizumab in Patients with Metastatic NSCLC
Author(s): Rajiv Kumar- Abstract
Loading...